Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Crispr Therapeutics Ag
(NQ:
CRSP
)
48.69
+1.19 (+2.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crispr Therapeutics Ag
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Can Vertex Pharmaceuticals Recover From Its Latest Setback?
June 15, 2021
Shares of the biotech industry leader have taken a big hit thanks to a clinical development pipeline that hasn't produced any big wins lately.
Via
The Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
June 15, 2021
This biotech has likely reached its peak potential, for now.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2021
June 14, 2021
Upgrades Piper Sandler upgraded the previous rating for Boston Properties Inc (NYSE:BXP) from Neutral to Overweight. Boston Properties earned $1.56 in the first quarter,...
Via
Benzinga
Why CRISPR Therapeutics Stock Is Trading Higher Today
April 26, 2021
CRISPR Therapeutics (NASDAQ:CRSP) shares are trading higher after the company and ...
Via
Benzinga
Why CRISPR Therapeutics Is Trading Higher Today
April 21, 2021
The Price And Volume Action In CRISPR Therapeutics's Stock Today CRISPR Therapeutics's (NASDAQ:
Via
Benzinga
10 Biggest Price Target Changes For Monday
June 14, 2021
Needham raised OrthoPediatrics Corp. (NASDAQ: KIDS) price target from $70 to $77. Vertex Pharmaceuticals shares rose 0.2% to close at $63.51 on Friday. HC Wainwright & Co....
Via
Benzinga
Why Crispr's Gene-Editing Jump Wasn't Enough To Help Vertex Stock
June 11, 2021
Vertex Pharmaceuticals and Crispr Therapeutics appeared Friday to be making progress on a cure for two blood diseases. But only CRSP stock popped.
Via
Investor's Business Daily
Vertex, Crispr Unveil More Encouraging Data From Sickle Cell, Thalassemia Gene Therapy Trials
June 11, 2021
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and Crispr Therapeutics AG (NASDAQ: CRSP) have announced new data from Phase 1/2 clinical trials...
Via
Benzinga
Vertex and CRISPR Therapeutics Present New Data in 22 Patients With Greater Than 3 Months Follow-Up Post-Treatment With Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at European Hematology Association Annual Meeting
June 11, 2021
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
June 07, 2021
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...
Via
Benzinga
Exposures
Product Safety
What's the Best Way to Invest in Genetics Stocks?
June 07, 2021
Here are some of our experts' favorite gene editing plays for the long run.
Via
The Motley Fool
How Much Will the Nkarta Deal Help CRISPR Therapeutics?
June 06, 2021
Unfortunately, this isn't an endorsement by a big drug developer.
Via
The Motley Fool
1 Genetics Stock to Put on Your Radar
June 04, 2021
Some of our experts think this stock has tons of long-term potential.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Cathie Wood's Ark Loads Up Further On Tesla And Cuts Apple Stake
May 19, 2021
Cathie Wood-led Ark Investment Management on Tuesday snapped up $27.2 million worth of shares in Tesla Inc (NASDAQ: TSLA) after a two-week gap during which shares of the...
Via
Benzinga
3 Healthcare Stocks That Might Soar if Biden Gets This Part of His Budget Approved
May 12, 2021
A new agency could help fund the attack on this chronic disease.
Via
The Motley Fool
Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat
May 12, 2021
Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics...
Via
Benzinga
ARKK Stocks Breakdowns and Bounces
May 07, 2021
After struggling for most of the past couple of months, momentum and Tech stocks are broadly outperforming today.
Via
Talk Markets
Nkarta, CRISPR Join Forces On CAR-NK Development For Cancer
May 07, 2021
Nkarta Inc (NASDAQ: NKTX) has collaborated with CRISPR Therapeutics AG(NASDAQ: CRSP) to co-develop and commercialize two CAR-NK therapies, in addition to an NK+T...
Via
Benzinga
With 1 Cure Behind It, This Breakthrough Biotech Takes Aim at a Bigger Market
May 07, 2021
One company is setting itself apart in a crowded field.
Via
The Motley Fool
This Bold Statement by the Vertex CEO Means a New Blockbuster May be Here Soon
May 04, 2021
The cystic fibrosis specialist is moving into other lucrative areas.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Will Vertex's Sickle Cell Gambit Sink bluebird bio's Stock?
May 01, 2021
The competition is starting to heat up, but bluebird is far from finished.
Via
The Motley Fool
Best Biotech Stocks & ETFs for mRNA, Gene Editing
April 29, 2021
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space.
Via
Talk Markets
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
Skyworks Lifts Nasdaq Ahead of Earnings; CRISPR Keeps Moving Forward
April 26, 2021
The Nasdaq gained ground to start the week.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Why Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving Today
April 26, 2021
Voyager Therapeutics, Inc. (NASDAQ: VYGR), uniQure N.V. (NASDAQ: QURE), Axsome Therapeutics, Inc. (NASDAQ: AXSM), Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) and CRISPR...
Via
Benzinga
2 Unstoppable Cathie Wood Stocks That Could Make You Rich
April 23, 2021
Both of these stocks have struggled in recent weeks, which means it might be a good time to initiate a position.
Via
The Motley Fool
Exposures
COVID-19
3 Top Value Stocks in Healthcare to Buy Right Now
April 21, 2021
Well-known guidance from Warren Buffett can help us identify opportunities in an expensive market.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021
April 21, 2021
Upgrades For Cerecor Inc (NASDAQ:CERC), Maxim Group upgraded the previous rating of Hold to Buy. In the fourth quarter, Cerecor showed an EPS of $0.19, compared to $0.10...
Via
Benzinga
46 Biggest Movers From Yesterday
April 21, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares jumped 27.3% to close at $9.79 on Tuesday after the company reported inducement grants. The company recently said it...
Via
Benzinga
Vertex Pharmaceuticals Raises Bet on CRISPR Therapeutics
April 20, 2021
The amended collaboration agreement comes with a big up-front payment.
Via
The Motley Fool
< Previous
1
2
...
22
23
24
25
26
27
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.